Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Biomedical Research Institute, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Europace. 2022 Jul 21;24(7):1093-1101. doi: 10.1093/europace/euac005.
Posterior wall isolation (PWI) of the left atrium (LA) adjunct to pulmonary vein isolation (PVI) by radiofrequency catheter ablation has shown favourable outcomes in patients with persistent atrial fibrillation (PeAF). This study was sought to investigate the efficacy and safety of additional PWI by cryoballoon ablation (CBA) alone in patients with PeAF.
Patients who underwent de novo CBA for PeAF (n = 100) were randomly assigned (1 : 1) to the PVI only group and PVI combined with PWI (PVI+PWI) group. Procedural and clinical outcomes were prospectively compared over a 12-month follow-up.
Baseline characteristics, including mean AF duration (56.2 ± 43.2 months) and LA size (48.2 ± 7.7 mm), were well-balanced between the groups. Successful PVI was achieved in all patients. In the PVI+PWI group, complete PWI by CBA was achieved in 31 (62%) patients. The LA indwelling and procedure times were significantly longer in the PVI+PWI group. The complication rates were not different between groups. During a mean follow-up of 457.9 ± 61.8 days, the recurrence rate of atrial tachyarrhythmia was significantly lower in the PVI+PWI group than in the PVI only group (24% vs. 46%; P = 0.035). The recurrence-free survival rate was significantly higher in the PVI+PWI group compared with the PVI only group, irrespective of complete PWI (log-rank P = 0.013). Multivariate analysis showed that adjunctive PWI [hazard ratio (HR) 0.255; P = 0.003] and LA size (HR 1.079; P = 0.014) were independent predictors of clinical recurrence.
Compared with PVI only, adjunctive PWI achieved exclusively by CBA resulted in better clinical outcomes without increasing complications in patients with PeAF.
左心房(LA)后壁隔离(PWI)联合射频导管消融肺静脉隔离(PVI)在持续性心房颤动(PeAF)患者中显示出良好的效果。本研究旨在探讨单独使用冷冻球囊消融(CBA)行额外 PWI 治疗 PeAF 的疗效和安全性。
100 例新行 CBA 治疗的 PeAF 患者按 1:1 随机分为 PVI 组和 PVI 联合 PWI 组(PVI+PWI 组)。前瞻性比较两组 12 个月的随访期间的手术和临床结局。
两组基线特征,包括平均房颤持续时间(56.2±43.2 个月)和左心房大小(48.2±7.7mm),均无显著差异。所有患者均成功实现 PVI。在 PVI+PWI 组中,31 例(62%)患者通过 CBA 实现完全 PWI。PVI+PWI 组 LA 留置时间和手术时间显著长于 PVI 组。两组并发症发生率无差异。平均随访 457.9±61.8 天后,PVI+PWI 组房性快速心律失常复发率明显低于 PVI 组(24% vs. 46%;P=0.035)。PVI+PWI 组无论是否实现完全 PWI,其无复发生存率均明显高于 PVI 组(log-rank P=0.013)。多因素分析显示,附加 PWI(风险比[HR]0.255;P=0.003)和左心房大小(HR 1.079;P=0.014)是临床复发的独立预测因素。
与单纯 PVI 相比,附加的 PWI 仅通过 CBA 实现可改善 PeAF 患者的临床结局,而不会增加并发症。